Objetivo - To better understand the pathophysiology of invasive amebiasis through analysing the host-parasite interrelation in human infections of the intestinal parasite Entamoeba histolytica at the molecular, clinical and epidemiological level.- Monoclonal antibodies were produced that specifically recognise native and fixed cysts of E. histolytica as well as against native and fixed cysts of E. dispar. Serological studies have shown that E. dispar itself can elicit a specific serum antibody response. An improved method based on the PCR-SHELA technique has been developed to identify E. histolytica and E. dispar in human faeces. This method is suitable for use with large numbers of specimens.- The prevalences of E. histolytica and E. dispar were determined separately in Eastern Turkey using stool microscopy, PCR and serological methods. According to PCR classification the prevalence of E. dispar was 13% whereas not a single case of E. histolytica was detected. Anti-E. histolytica serum antibodies were found in 0.6% of the population using an ELISA with a recombinant antigen. It is concluded that the prevalence of E. dispar in the Diyarbakir area is high but that the prevalence of E. histolytica is very low.- The presence of gene of cysteine proteinase 1 (ACP1) in non pathogenic E. dispar strains was demonstrated.- Episomal transfection and continuous expression of heterologous genes in E. dispar were achieved. This is the first report of stable expression of a foreign gene in E. dispar using upstream and downstream regulatory sequences of E. histolytica ribosomal protein L21 gene. Using solvent extraction as well as hydrophobic and anion exchange chromatography, two distinct lipid-anchored glycolipids whose composition was indicative of an LPG and a lipophosphopeptidoglyan (LPPG) were characterised. A direct correlation was observed between the relative abundance of these molecules in different amebic isolates and their virulence. A novel monoclonal antibody that reacts with the LPG of virulent strains has been cloned.- Monoclonal antibodies selectively recognizing only cysts of pathogenic Entamoeba histolytica or non-pathogenic Entamoeba dispar are developed;- Antigens recognized by monoclonal antibodies are examined in order to assess their location and functional significance;- Entamoeba histolytica and Entamoeba dispar are detected and differentiated using an improved colorimetric polymerase chain reaction method directly from faecal samples;- Cell surface molecules of pathogenic E. histolytica and nonpathogenic E. dispar and their relation to virulence are examined;- Epidemiologic studies are under way in Diyarbakir/Turkey and in Cairo/Egypt in order to assess the prevalence of E. histolytica infections. Programa(s) IC-AVICENNE - Avicenne Initiative (Science and technology cooperation with the Maghreb and the countries of the Mediterranean Basin), 1991- Tema(s) Data not available Convocatoria de propuestas Data not available Régimen de financiación CSC - Cost-sharing contracts Coordinador THE UNIVERSITY OF TUEBINGEN Aportación de la UE Sin datos Dirección 27,Wilhelmstrasse 27 72074 TUEBINGEN Alemania Ver en el mapa Coste total Sin datos Participantes (4) Ordenar alfabéticamente Ordenar por aportación de la UE Ampliar todo Contraer todo Al-Azhar University Egipto Aportación de la UE Sin datos Dirección 1891,Al-Darasa Cairo Ver en el mapa Coste total Sin datos Dicle University Turquía Aportación de la UE Sin datos Dirección 21280 Diyarbakir Ver en el mapa Coste total Sin datos London School of Hygiene and Tropical Medicine Reino Unido Aportación de la UE Sin datos Dirección Keppel Street WC1E 7HT London Ver en el mapa Coste total Sin datos Weizmann Institute of Science - National Council for Research and Development Israel Aportación de la UE Sin datos Dirección 76100 Rehovot Ver en el mapa Coste total Sin datos
